Company Filing History:
Years Active: 2009
Title: Innovations by Inventor Hung-Wei Chih
Introduction
Hung-Wei Chih is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of drug development, particularly in the area of antibody-drug conjugates. His work focuses on creating effective therapeutic compositions that can target and kill specific cells.
Latest Patents
Hung-Wei Chih holds a patent for a drug conjugate composition. This invention provides both a liquid composition and a lyophilized composition that includes a therapeutically effective amount of a conjugate comprising an antibody chemically coupled to a maytansinoid. The patent outlines a method for killing a cell in a human by administering either of the compositions, allowing the antibody to bind to the surface of the cell and activate the cytotoxicity of the maytansinoid, ultimately leading to cell death. He has 1 patent to his name.
Career Highlights
Hung-Wei Chih is currently associated with Immunogen, Inc., a company that specializes in developing innovative antibody-drug conjugates for cancer treatment. His work at Immunogen has positioned him as a key player in advancing therapeutic options for patients.
Collaborations
Some of his notable coworkers include Godfrey W Amphlett and Wei Zhang. Their collaborative efforts contribute to the ongoing research and development of effective cancer therapies.
Conclusion
Hung-Wei Chih's innovative work in drug conjugate compositions exemplifies the potential of targeted therapies in medicine. His contributions continue to influence the field of oncology and improve treatment outcomes for patients.